Covid-19: This scanning electron microscope image shows SARS-CoV-2 (colored in orange) isolated from a patient in the US. Credit: NIAID-RML.

Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates

Follow the latest updates of the outbreak on our timeline.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Vingroup Innovation Foundation (VINIF) is set to fund coronavirus research projects by The Company for Vaccine and Biological Production No 1 (Vabiotech), Pasteur Institute in Ho Chi Minh City and Institute of Preventive Medicine and Public Health.

Of the total VND20bn ($857,000), Vabiotech will receive VND8bn ($343,000) to develop vaccines for the coronavirus. The project will involve growing Baculoviruses medium at laboratory scale.

The company is expected to generate 1,000 doses of coronavirus vaccine.

VINIF is providing Institute of Preventive Medicine and Public Health with VND4bn ($171,000) to devise an early warning system for the Covid-19 outbreak. The statistical model will be designed to review infection risk and develop an emergency response plan.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The remaining grant of approximately VND7.5bn ($321,000) will be given to Pasteur Institute in Ho Chi Minh City for supporting research on epidemiological characteristics of the new coronavirus in Vietnam.

VINIF managing director Phan Thi Ha Duong said: “Aiming to promote scientific and technological research in Vietnam, in the context of complicated and endemic disease situation, we look forward to empowering scientists in research on disease prevention and control which will be very effective with the cooperation of the State.

“Despite being urgent, the selected projects have been reviewed strictly by the National Council or the Science Council of the Foundation.”

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Awarded the 2025 Pharmaceutical Technology Excellence Award for Business Expansion in Integrated Manufacturing, Upperton Pharma Solutions is rapidly expanding its UK GMP and sterile manufacturing footprint. Find out how Upperton’s integrated CDMO model helps pharma companies move from early development to clinical and niche commercial supply with fewer handovers and faster timelines.

Discover the Impact